APA (7th ed.) Citation

Faleti, O. D., Alsaadawe, M., Long, J., Luo, Q., Hu, L., Zhang, Y., . . . Lyu, X. (2025). Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib’s efficacy. Nature communications, 16(1), 1. https://doi.org/10.1038/s41598-025-00832-7

Chicago Style (17th ed.) Citation

Faleti, Oluwasijibomi Damola, et al. "Dimethyl Fumarate Abrogates Hepatocellular Carcinoma Growth by Inhibiting Nrf2/Bcl-xL Axis and Enhances Sorafenib’s Efficacy." Nature Communications 16, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-00832-7.

MLA (9th ed.) Citation

Faleti, Oluwasijibomi Damola, et al. "Dimethyl Fumarate Abrogates Hepatocellular Carcinoma Growth by Inhibiting Nrf2/Bcl-xL Axis and Enhances Sorafenib’s Efficacy." Nature Communications, vol. 16, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-00832-7.